Search Results
Search for other papers by Jaydira Del Rivero in
Google Scholar
PubMed
Search for other papers by Josh Mailman in
Google Scholar
PubMed
Search for other papers by Michael W Rabow in
Google Scholar
PubMed
Search for other papers by Jennifer A Chan in
Google Scholar
PubMed
Search for other papers by Sarah Creed in
Google Scholar
PubMed
Search for other papers by Hagen F Kennecke in
Google Scholar
PubMed
Search for other papers by Janice Pasieka in
Google Scholar
PubMed
Search for other papers by Jennifer Zuar in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
Search for other papers by Lauren Fishbein in
Google Scholar
PubMed
How do we define palliative care, and when should it be started? Palliative care is a medical subspecialty that focuses on alleviating the symptoms and stress associated with serious medical illness. Palliative care is appropriate for any
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Search for other papers by Jack Junjie Chan in
Google Scholar
PubMed
Division of Surgery & Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
SingHealth Duke-NUS Breast Centre, Singapore General Hospital, Singapore, Singapore
Search for other papers by Yirong Sim in
Google Scholar
PubMed
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Search for other papers by Samuel Guan Wei Ow in
Google Scholar
PubMed
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Search for other papers by Joline Si Jing Lim in
Google Scholar
PubMed
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore
Search for other papers by Grace Kusumawidjaja in
Google Scholar
PubMed
Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore, Singapore
Search for other papers by Qingyuan Zhuang in
Google Scholar
PubMed
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore
Search for other papers by Ru Xin Wong in
Google Scholar
PubMed
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore
Search for other papers by Fuh Yong Wong in
Google Scholar
PubMed
Division of Surgery & Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
SingHealth Duke-NUS Breast Centre, Singapore General Hospital, Singapore, Singapore
Search for other papers by Veronique Kiak Mien Tan in
Google Scholar
PubMed
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Search for other papers by Tira Jing Ying Tan in
Google Scholar
PubMed
. Cancer care services During the ‘circuit breaker’ period in Singapore, hospital-based cancer care services, inpatient hospices and home palliative care are considered as essential and remain operational. Otherwise, cancer screening and surveillance
Search for other papers by Simon Garinet in
Google Scholar
PubMed
Search for other papers by Juliette Nectoux in
Google Scholar
PubMed
Search for other papers by Mario Neou in
Google Scholar
PubMed
INSERM UMR745, Biological and Pharmaceutical Sciences University, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
Search for other papers by Eric Pasmant in
Google Scholar
PubMed
Department of Medical Oncology, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Paris, France
Search for other papers by Anne Jouinot in
Google Scholar
PubMed
Search for other papers by Mathilde Sibony in
Google Scholar
PubMed
Search for other papers by Lucie Orhant in
Google Scholar
PubMed
Search for other papers by Juliana Pipoli da Fonseca in
Google Scholar
PubMed
Search for other papers by Karine Perlemoine in
Google Scholar
PubMed
Search for other papers by Léopoldine Bricaire in
Google Scholar
PubMed
Department of Endocrinology, Cochin Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Search for other papers by Olivier Soubrane in
Google Scholar
PubMed
Search for other papers by Bertrand Dousset in
Google Scholar
PubMed
Department of Endocrinology, Cochin Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
Search for other papers by Rossella Libe in
Google Scholar
PubMed
Search for other papers by Franck Letourneur in
Google Scholar
PubMed
Department of Endocrinology, Cochin Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
Reference Center for Rare Adrenal Diseases, Reference Center for Rare Adrenal Cancer Network COMETE, Hôpital Cochin, AssistancePublique – Hôpitaux de Paris, Paris, France
Search for other papers by Jérome Bertherat in
Google Scholar
PubMed
Department of Endocrinology, Cochin Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France
Reference Center for Rare Adrenal Diseases, Reference Center for Rare Adrenal Cancer Network COMETE, Hôpital Cochin, AssistancePublique – Hôpitaux de Paris, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
since only a biopsy was performed; ## palliative care only at this time; # deceased from pulmonary infection after surgery; $ determined on a lung metastases. A, androgens; GC, glucocorticoids; MC, minerlocorticoïds. Tumor and leukocytes DNA
Search for other papers by Katherine I Wolf in
Google Scholar
PubMed
Search for other papers by Linda Rose-Krasnor in
Google Scholar
PubMed
Search for other papers by Stephanie Alband in
Google Scholar
PubMed
Search for other papers by Jacques W M Lenders in
Google Scholar
PubMed
Search for other papers by Lauren Fishbein in
Google Scholar
PubMed
$2500 for health insurance, 13 had an annual cost of over $10,000/year. Figure 3 Personal financial burden related to pheochromocytoma/paraganglioma diagnosis and treatment. *Clinical nurse care, emergency medicine services, palliative care
Search for other papers by Kristen Wong in
Google Scholar
PubMed
Search for other papers by Francesca Di Cristofano in
Google Scholar
PubMed
Search for other papers by Michela Ranieri in
Google Scholar
PubMed
Search for other papers by Daniela De Martino in
Google Scholar
PubMed
Search for other papers by Antonio Di Cristofano in
Google Scholar
PubMed
Introduction Anaplastic thyroid carcinoma (ATC) is the most aggressive thyroid cancer subtype, with a median overall survival of less than 9 months when patients are treated with multimodal therapy and less than 3 months with palliative care
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain
Endocrinology and Nutrition Service, Reina Sofia University Hospital, Córdoba, Spain
Search for other papers by Aura D Herrera-Martínez in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
is generally seen in patients with liver metastases ( Grahame-Smith 1970 ). Consequently, the majority of CS patients cannot be treated with curative intention. The management of CS thus forms an important part of palliative care in this patient
Section on Endocrinology Genetics, Pediatric Endocrinology Inter-Institute Training Program, Program on Developmental Endocrinology Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Search for other papers by Maya B Lodish in
Google Scholar
PubMed
Section on Endocrinology Genetics, Pediatric Endocrinology Inter-Institute Training Program, Program on Developmental Endocrinology Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Search for other papers by Constantine A Stratakis in
Google Scholar
PubMed
in metastatic renal cell carcinoma . Current Opinion in Supportive and Palliative Care 3 170 – 179 doi:10.1097/SPC.0b013e32832e4681 . Gupta-Abramson V Troxel AB Nellore A Puttaswamy K Redlinger M Ransone K Mandel SJ Flaherty KT
Urology Department of Development and Regeneration, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Laboratory for Structural Bioinformatics Center for Life Science Technologies, RIKEN, Yokohama, Japan
Search for other papers by Christine Helsen in
Google Scholar
PubMed
Urology Department of Development and Regeneration, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Laboratory for Structural Bioinformatics Center for Life Science Technologies, RIKEN, Yokohama, Japan
Laboratory of Molecular Endocrinology Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium
Urology Department of Development and Regeneration, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Laboratory for Structural Bioinformatics Center for Life Science Technologies, RIKEN, Yokohama, Japan
Search for other papers by Thomas Van den Broeck in
Google Scholar
PubMed
Urology Department of Development and Regeneration, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Laboratory for Structural Bioinformatics Center for Life Science Technologies, RIKEN, Yokohama, Japan
Search for other papers by Arnout Voet in
Google Scholar
PubMed
Urology Department of Development and Regeneration, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Laboratory for Structural Bioinformatics Center for Life Science Technologies, RIKEN, Yokohama, Japan
Search for other papers by Stefan Prekovic in
Google Scholar
PubMed
Urology Department of Development and Regeneration, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Laboratory for Structural Bioinformatics Center for Life Science Technologies, RIKEN, Yokohama, Japan
Search for other papers by Hendrik Van Poppel in
Google Scholar
PubMed
Urology Department of Development and Regeneration, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Laboratory for Structural Bioinformatics Center for Life Science Technologies, RIKEN, Yokohama, Japan
Search for other papers by Steven Joniau in
Google Scholar
PubMed
Urology Department of Development and Regeneration, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Laboratory for Structural Bioinformatics Center for Life Science Technologies, RIKEN, Yokohama, Japan
Search for other papers by Frank Claessens in
Google Scholar
PubMed
Taylor RP Mohler ML Steiner MS 2013 Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer . Current Opinion in Supportive and Palliative Care 7 345 – 351 . ( doi:10.1097/SPC
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Search for other papers by Martin O Weickert in
Google Scholar
PubMed
Search for other papers by Harpal S Randeva in
Google Scholar
PubMed
Division of Pathophysiology, National and Kapodistrian University of Athens Medical School, Athens, Greece
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
suggested that in patients with malignancy the use of an ADH receptor antagonist could improve hyponatraemic symptoms even in patients on palliative care. More studies are required to address the potential safety concerns of chronic use, because tolvaptan, a
Search for other papers by S Kato in
Google Scholar
PubMed
Search for other papers by M F Liberona in
Google Scholar
PubMed
Department of Cellular and Molecular, Faculty of Biological Sciences, PUC, Santiago, Chile
Search for other papers by J Cerda-Infante in
Google Scholar
PubMed
Search for other papers by M Sánchez in
Google Scholar
PubMed
Search for other papers by J Henríquez in
Google Scholar
PubMed
Search for other papers by C Bizama in
Google Scholar
PubMed
Millennium Institute on Immunology and Immunotherapy, PUC, Santiago, Chile
Search for other papers by M L Bravo in
Google Scholar
PubMed
Search for other papers by P Gonzalez in
Google Scholar
PubMed
Search for other papers by R Gejman in
Google Scholar
PubMed
Search for other papers by J Brañes in
Google Scholar
PubMed
Search for other papers by K García in
Google Scholar
PubMed
Millennium Institute on Immunology and Immunotherapy, PUC, Santiago, Chile
Search for other papers by C Ibañez in
Google Scholar
PubMed
Millennium Institute on Immunology and Immunotherapy, PUC, Santiago, Chile
Search for other papers by G I Owen in
Google Scholar
PubMed
Millennium Institute on Immunology and Immunotherapy, PUC, Santiago, Chile
Search for other papers by J C Roa in
Google Scholar
PubMed
Search for other papers by V Montecinos in
Google Scholar
PubMed
Search for other papers by M A Cuello in
Google Scholar
PubMed
respond to consecutive rescue schemes), in palliative care and was using alternative medicine. Simultaneously, she underwent paracentesis, twice a week, to alleviate symptoms from recurrent massive ascites. Due to shortening in symptomatic relief after